Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

The US Chamber of Commerce has published its International IP Index 2020, a map of the IP ecosystems of 53 economies, representing over 90% of global gross domestic product (GDP). The index aims to provide a snapshot of each economy’s overall IP ecosystem by evaluating its IP framework across 50 indicators, selected to represent the most effective IP systems.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

Report slams big pharma influence in EU-funded project

28 May 2020 A new NGO report has sharply criticised the EU-funded Innovative Medicines Initiative as favouring Big Pharma over small businesses, particularly when it comes to IP.

Big Pharma

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

15 May 2020 The CJEU’s decision in Royalty Pharma has provided much-anticipated guidance on supplementary protection certificates but has left a lot of uncertainty. Was this the best the CJEU could come up with? Beatriz San Martin of Arnold & Porter reports.

More on this story

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

Report slams big pharma influence in EU-funded project

28 May 2020 A new NGO report has sharply criticised the EU-funded Innovative Medicines Initiative as favouring Big Pharma over small businesses, particularly when it comes to IP.

Big Pharma

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

More on this story

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

Report slams big pharma influence in EU-funded project

28 May 2020 A new NGO report has sharply criticised the EU-funded Innovative Medicines Initiative as favouring Big Pharma over small businesses, particularly when it comes to IP.

Big Pharma

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity